pfizer 3sbio - Search News

Order byBest matchMost fresh

News

Pfizer Strikes Deal With China's 3SBio

· 10h · on MSN

Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China

Key Takeaways Pfizer said late Monday that it has agreed to a deal to help develop and market a Chinese cancer drug across the globe.Chinese firm 3SBio is developing a drug that is in trials to treat several forms of cancer,

Continue reading

Pfizer Thinks Bigger With 3SBio Deal

GlobalData on MSN · 15h

Pfizer signs global licensing deal with 3SBio for bispecific antibody

Fierce Biotech15h

Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific, joining red-hot race with BioNTech, Merck

Pfizer has joined the PD-1xVEGF bispecific gold rush. The Big Pharma is paying 3SBio $1.25 billion upfront for ex-China ...

Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Pfizer Puts $6B on the Line For 3SBio’s PD-1/VEGF Antibody

The agreement comes three months after Pfizer inked a PD-1/VEGF partnership with Summit Therapeutics, leading BMO Capital ...

10h

Stock Movers: Home Depot, 3SBio-Pfizer, UNH

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results